ZYDUS PHARMS USA INC FDA Approval ANDA 214502

ANDA 214502

ZYDUS PHARMS USA INC

FDA Drug Application

Application #214502

Documents

Letter2022-01-12

Application Sponsors

ANDA 214502ZYDUS PHARMS USA INC

Marketing Status

Prescription001

Application Products

001TABLET; ORAL10MG0PIMAVANSERINPIMAVANSERIN

FDA Submissions

UNKNOWN; ORIG1TA2021-12-21STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

ZYDUS PHARMS USA INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214502
            [companyName] => ZYDUS PHARMS USA INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"PIMAVANSERIN","activeIngredients":"PIMAVANSERIN","strength":"10MG","dosageForm":"TABLET; ORAL","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"12\/21\/2021","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2022\\\/214502Orig1s000TA_ltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-12-21
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.